In recent months, evidence suggests, the war in Ukraine and the ongoing conflict in Gaza have led to spikes of multidrug-resistant bacterial infections. This is to be expected;
For most states, the new year means a new legislative session. STAT’s taking a look at some of the recent health policy trends that states
A slate of liver diseases got a rebrand this year. Experts hope the change can generate more conversation — and research interest — for conditions
Health insurance giant UnitedHealth Group used secret rules to restrict access to rehabilitation care requested by specific groups of seriously ill patients, including those who
There’s an old story in journalism, and it goes like this: A reporter is asked, “What’s the best story you’ve ever written?” The reply? “The
Low-carbohydrate diets comprised mostly of plant-based proteins and fats with healthy carbohydrates such as whole grains were associated with slower long-term weight gain than low-carbohydrate
The Congressional Budget Office expects that drugmakers will raise their prices and offer larger rebates for new drugs because of provisions in the Inflation Reduction
Cytokinetics’ experimental medicine for a genetic heart condition known as hypertrophic cardiomyopathy helped patients do significantly better on an exercise test that’s used to measure
Plus, news on the Immunome-Atreca asset deal, Nestlé buying CDX-7108 from Codexis, Oncternal, Visiox and more. Immunome acquires Atreca antibody assets: Immunome will purchase antibody-related
The FDA placed a clinical hold on a registrational trial of Iovance Biotherapeutics’ tumor-infiltrating lymphocyte, or TIL, therapy LN-145 after a patient death in the